好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2020 Annual Meeting | C258 - Vascular Cognitive Impairment and Dementia: Current Status and Future

Friday 05/01/20
07:00 AM - 09:00 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Mark R. Etherton, MD
Aging, Dementia, and Behavioral Neurology
Participants should be able to discuss the diagnostic challenges and current and potential future therapeutic approaches for the management of vascular cognitive impairment and dementia.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student
Didactic
Event Timeline
07:00 AM - 07:25 AM Speaker Vascular Cognitive Impairment/Dementia: Understanding the Clinical Impact
Mark R. Etherton, MD
07:25 AM - 07:30 AM Q&A Questions and Answers
Mark R. Etherton, MD
07:30 AM - 08:05 AM Speaker
James F. Meschia, MD, FAAN
08:05 AM - 08:10 AM Q&A Questions and Answers
James F. Meschia, MD, FAAN
08:10 AM - 08:45 AM Speaker Therapeutic Strategies for Patients with Vascular Cognitive Impairment/Dementia
Alessandro Biffi, MD
08:45 AM - 08:50 AM Q&A Questions and Answers
Alessandro Biffi, MD
08:50 AM - 09:00 AM Closing Remarks Closing Remarks
Mark R. Etherton, MD
Faculty Disclosures
Mark R. Etherton, MD Dr. Etherton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WorldCare Clinical. Dr. Etherton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Etherton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clarion Healthcare. Dr. Etherton has received research support from 好色先生. Dr. Etherton has received research support from MGH Executive Council on Research. Dr. Etherton has received research support from NINDS. Dr. Etherton has received publishing royalties from a publication relating to health care.
Alessandro Biffi, MD Dr. Biffi has received personal compensation for serving as an employee of Eli Lilly And Company. Dr. Biffi has stock in Eli Lilly And Company.
James F. Meschia, MD, FAAN The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.